Celebrating Wild Caraway: Taste of Nova Scotia's Restaurant of the Year | SaltWire - Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternatives.
The announcement comes eight months after Novo said it would cut U.S. list prices for several of its insulin products next year, including a 65% reduction in the list price of Levemir, in response to mounting political pressure over insulin prices. The announcement followed a similar one by Eli Lilly.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: YahooFinanceCA - 🏆 47. / 63 Lire la suite »
La source: YahooFinanceCA - 🏆 47. / 63 Lire la suite »